STRS Ohio’s Citius Pharmaceuticals CTXR Stock Holding History

STRS Ohio’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-148	Closed	-$6K	–	2093
2022 Q1	$6K	Hold	148	–	–	﹤0.01%	2107
2021 Q4	$5K	Hold	148	–	–	﹤0.01%	2163
2021 Q3	$7K	Sell	148 -904	-86%	-$45.4K	﹤0.01%	2209
2021 Q2	$91K	Buy	+1,052	New	+$63.2K	﹤0.01%	1994

Other funds holding CTXR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

STRS Ohio's CTXR Position: Q2 2022 in Review

STRS Ohio sold out of Citius Pharmaceuticals (CTXR) in Q2 2022, closing a stake of 148 shares — an estimated $6K sold.

STRS Ohio first reported a position in CTXR in Q2 2021 and held it in 4 quarters. The position peaked at $91K in Q2 2021. 60 funds tracked by Wall St. Rank hold CTXR as of Q2 2022.

STRS Ohio reported no remaining Citius Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 148 Citius Pharmaceuticals shares in Q2 2022, an estimated $6K.
STRS Ohio first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 4 quarters.
STRS Ohio's Citius Pharmaceuticals position peaked at $91K in Q2 2021.
60 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.